모바일 헬스(mHealth) 시장 보고서 : 컴포넌트, 서비스, 시장 진출기업, 지역별(2025-2033년)

The global mHealth market size reached USD 110.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 594.3 Billion by 2033, exhibiting a growth rate (CAGR) of 19.57% during 2025-2033.

Mobile health (mHealth) is a diversified branch of electronic health (eHealth) that collects patient data using mobile devices and wireless infrastructure. The collected data assists in obtaining accurate results that are utilized to treat and diagnose several medical conditions. mHealth assists in improving medication adherence and communication, allows remote patient monitoring and enables patients to send secure messages, connect to service providers and schedule appointments. As a result, it finds extensive application in healthcare supply chain management, diagnostic and treatment support, chronic disease monitoring and management and increasing health awareness among people. At present, mHealth technology is gaining popularity across the globe for home-based patient monitoring services among the geriatric population.

The rising dependence on mobile devices represents one of the key factors strengthening the global mHealth market growth. These devices enable individuals to access healthcare-related services via wireless multimedia easily. Moreover, mHealth solutions have user-friendly characteristics and offer efficiency during an emergency. This, in confluence with the increasing instances of chronic diseases, such as diabetes and hypertension, is positively influencing the market growth worldwide. Furthermore, the key manufacturers are integrating innovative technologies to support the healthcare industry, which, in turn, is fostering the market growth. For instance, the US Food and Drug Administration (FDA) announced the launch of an internet-based repository, CURE ID, in December 2019 that enabled the clinical community to report their experiences of treating infectious diseases with the existing FDA-approved drugs through smartphones, websites or other mobile devices.

Key Market Segmentation:

Breakup by Component:

• Wearables
  • Blood Pressure Monitors
  • Blood Glucometer
  • Pulse Oximeter
  • Neurological Monitors
  • Others
• mHealth Apps
  • Medical Apps
  • Fitness Apps

Breakup by Service:

• Monitoring Services
• Diagnosis Services
• Healthcare Systems Strengthening Services
• Treatment Services
• Others

Breakup by Participants:

• mHealth Application Companies
• Pharmaceuticals Companies
• Hospitals
• Health Insurance Companies
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Airstrip Technologies Inc., Allscripts Healthcare Solutions Inc., Apple Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Koninklijke Philips N.V., Masimo Corporation, Omron HealthCare Inc. (OMRON Corporation), Qualcomm Incorporated, Samsung Electronics Co. Ltd. and Sanofi S.A.

Key Questions Answered in This Report:

• How has the global mHealth market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global mHealth market?
• What are the key regional markets?
• What is the breakup of the market based on the component?
• What is the breakup of the market based on the service?
• What is the breakup of the market based on the participants?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global mHealth market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global mHealth Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Component

• 6.1 Wearables
  • 6.1.1 Market Trends
  • 6.1.2 Major Types
    • 6.1.2.1 Blood Pressure Monitors
    • 6.1.2.2 Blood Glucometer
    • 6.1.2.3 Pulse Oximeter
    • 6.1.2.4 Neurological Monitors
    • 6.1.2.5 Others
  • 6.1.3 Market Forecast
• 6.2 mHealth Apps
  • 6.2.1 Market Trends
  • 6.2.2 Major Types
    • 6.2.2.1 Medical Apps
    • 6.2.2.2 Fitness Apps
  • 6.2.3 Market Forecast

7 Market Breakup by Service

• 7.1 Monitoring Services
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnosis Services
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Healthcare Systems Strengthening Services
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Treatment Services
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Participants

• 8.1 mHealth Application Companies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceuticals Companies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Hospitals
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Health Insurance Companies
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Airstrip Technologies Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Allscripts Healthcare Solutions Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Apple Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Bayer Aktiengesellschaft
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Boston Scientific Corporation
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Koninklijke Philips N.V.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Masimo Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Omron HealthCare Inc. (OMRON Corporation)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Qualcomm Incorporated
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Samsung Electronics Co. Ltd.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Sanofi S.A.
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis